ORTX - Orchard Therapeutics plc - ADR
IEX Last Trade
5.07
-0.110 -2.170%
Share volume: 13,906
Last Updated: Tue 08 Aug 2023 06:51:43 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.18
-0.11
-2.12%
Summary score
19%
Profitability
25%
Dept financing
6%
Liquidity
40%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.1%
Return on assets
-12.09%
Return on sales
-6284.19%
Return on invested capital
74.27%
Total debt ratio
21.35%
Debt ratio change over timeo
-0.92%
Current Ratio
7.49%
Quick Ratio
0%
Cash Position Ratio
2.27%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.56%
Return on assets
-13.02%
Return on sales
-6284.19%
Return on invested capital
42.61%
Total debt ratio
24.11%
Debt ratio change over timeo
-0.94%
Current Ratio
6.97%
Quick Ratio
0%
Cash Position Ratio
0.68%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-20.97%
Return on assets
-16.08%
Return on sales
-8453.77%
Return on invested capital
-273.26%
Total debt ratio
27.83%
Debt ratio change over time
-1.07%
Current Ratio
6.07%
Quick Ratio
0%
Cash Position Ratio
0.98%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.06%
Return on assets
-104.38%
Return on sales
-1666.67%
Return on invested capital
34.88%
Total debt ratio
-92.01%
Debt ratio change over time
-0.92%
Current Ratio
2.13%
Quick Ratio
0%
Cash Position Ratio
-0.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.1% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.09% | 3.6% | 3.57% | 5.27% |
| Return on sales | -6284.19% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 74.27% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 70% | 63% |
| Total debt ratio | 21.35% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.92% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 6.97% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.68% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 23% | 44% | 49% |
| Short-term ratios | ORTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.56% | -25.62% | 17.94% | 7.14% |
| Return on assets | -13.02% | 3.26% | 3.67% | 4.71% |
| Return on sales | -6284.19% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 42.61% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 43% | 74% | 68% |
| Total debt ratio | 24.11% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.94% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 6.97% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.68% | 1.48% | 0.76% | 1.49% |
| Liquididy | 36% | 49% | 35% | 63% |